InvestmentMay 5, 2026, 05:27 PM
Aura Biosciences Raises $280.8M in Public Offering; Repurchases Shares
AI Summary
Aura Biosciences, Inc. completed an underwritten public offering, raising approximately $280.8 million in net proceeds. The offering included 39,591,000 shares of common stock and 3,800,000 pre-funded warrants, with underwriters fully exercising their option for additional shares. The company plans to allocate $241.8 million to advance clinical programs and for general corporate purposes, and $39.0 million to repurchase shares from Matrix Capital Management. This capital raise is expected to fund operations into the second half of 2028.
Key Highlights
- Aura Biosciences raised approximately $280.8 million in net proceeds from the offering.
- The offering included 39,591,000 shares of common stock and 3,800,000 pre-funded warrants.
- Shares were offered at $6.00 each, and pre-funded warrants at $5.99999 each.
- Underwriters fully exercised their option to purchase an additional 6,508,650 shares.
- Approximately $241.8 million of proceeds will fund clinical programs and general corporate purposes.
- The company will use $39.0 million to repurchase 6,922,870 shares from Matrix Capital Management.
- The offering extends the company's cash runway into the second half of 2028.
Price Impact
More from AURA